120 related articles for article (PubMed ID: 32885272)
21.
Hirmas N; Leyh C; Sraieb M; Barbato F; Schaarschmidt BM; Umutlu L; Nader M; Wedemeyer H; Ferdinandus J; Rischpler C; Herrmann K; Costa PF; Lange CM; Weber M; Fendler WP
J Nucl Med; 2021 Sep; 62(9):1235-1241. PubMed ID: 33509970
[TBL] [Abstract][Full Text] [Related]
22. 68Ga-PSMA Uptake in Hepatocellular Carcinoma.
Taneja S; Taneja R; Kashyap V; Jha A; Jena A
Clin Nucl Med; 2017 Jan; 42(1):e69-e70. PubMed ID: 27607177
[TBL] [Abstract][Full Text] [Related]
23. Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma.
Mena E; Shih J; Chung JY; Jones J; Rabiee A; Monge C; Turkbey B; Lindenberg L; Salerno KE; Kassin M; Wood B; Hernandez J; Maass-Moreno R; Saboury B; Jakhete N; Molitoris JK; Unger KR; Choyke PL; Escorcia FE
PLoS One; 2022; 17(11):e0277407. PubMed ID: 36367894
[TBL] [Abstract][Full Text] [Related]
24. Primary Hepatocellular Carcinoma With Intense 68Ga-PSMA Uptake But Slight 18F-FDG Uptake on PET/CT Imaging.
Erhamamci S; Aslan N
Clin Nucl Med; 2020 Mar; 45(3):e176-e177. PubMed ID: 31977478
[TBL] [Abstract][Full Text] [Related]
25. A Comprehensive Safety Evaluation of 68Ga-Labeled Ligand Prostate-Specific Membrane Antigen 11 PET/CT in Prostate Cancer: The Results of 2 Prospective, Multicenter Trials.
Nielsen JB; Zacho HD; Haberkorn U; Nielsen KM; Dettmann K; Langkilde NC; Petersen LJ
Clin Nucl Med; 2017 Jul; 42(7):520-524. PubMed ID: 28481791
[TBL] [Abstract][Full Text] [Related]
26. Radionuclide Therapy With 177 Lu-PSMA in a Patient With Hepatocellular Carcinoma.
Pretet V; Giraudet AL; Vergnaud L; Paquet E; Kryza D
Clin Nucl Med; 2024 Jun; 49(6):584-586. PubMed ID: 38630998
[TBL] [Abstract][Full Text] [Related]
27. 68Ga-PSMA Uptake in Combined Hepatocellular Cholangiocarcinoma With Skeletal Metastases.
Alipour R; Gupta S; Trethewey S
Clin Nucl Med; 2017 Oct; 42(10):e452-e453. PubMed ID: 28806238
[TBL] [Abstract][Full Text] [Related]
28. Incidental Intrahepatic Hepatocellular Cholangiocarcinoma Detected on 68Ga-PSMA PET/CT.
Kang C; Jiang JY; Lee ME; Shen L; Mansberg R
Clin Nucl Med; 2022 Mar; 47(3):e291-e293. PubMed ID: 35020661
[TBL] [Abstract][Full Text] [Related]
29. 68Ga-Prostate-Specific Membrane Antigen Expression in Neurocysticercosis Lesions in a Patient With Prostate Carcinoma.
Vadi SK; Kumar R; Singh H; Singh SK; Mittal BR
Clin Nucl Med; 2018 Apr; 43(4):e122-e124. PubMed ID: 29401150
[TBL] [Abstract][Full Text] [Related]
30. Differentiation of Discordant Lesions on Dual-Tracer PET/CT (
Chalikandy A; Yadav S; Basu S
J Nucl Med Technol; 2023 Dec; 51(4):339-342. PubMed ID: 37586854
[TBL] [Abstract][Full Text] [Related]
31.
Gao J; Meng L; Xu Q; Zhao X; Deng Y; Fu Y; Guo S; He K; Shi J; Wang F; Zhang S; Guo H
Mol Imaging Biol; 2022 Oct; 24(5):759-768. PubMed ID: 35451707
[TBL] [Abstract][Full Text] [Related]
32. Monitoring Dual-Cancer Treatment in a Patient With Prostate and Hepatocellular Carcinoma Using Prostate-Specific Membrane Antigen-Directed PET/CT.
Reiter FP; Weich A; Higuchi T; Serfling SE; Kickuth R; Werner RA
Clin Nucl Med; 2024 May; 49(5):442-443. PubMed ID: 38389205
[TBL] [Abstract][Full Text] [Related]
33. 68Ga-PSMA Uptake Patterns of Clear Cell Renal Carcinoma Across Different Histopathological Subtypes.
Oflas M; Ozluk Y; Sanli O; Ozkan ZG; Kuyumcu S
Clin Nucl Med; 2022 Jan; 47(1):e45-e46. PubMed ID: 34284482
[TBL] [Abstract][Full Text] [Related]
34. Preclinical evaluation of
Cai H; Li Z; Shi Q; Yang H; Xiao L; Li M; Lin H; Wu X; She T; Chen L; Li L; Lu X
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):2952-2961. PubMed ID: 37256321
[TBL] [Abstract][Full Text] [Related]
35. (68)Ga-PSMA PET/CT imaging in primary hepatocellular carcinoma.
Sasikumar A; Joy A; Nanabala R; Pillai MR; Thomas B; Vikraman KR
Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):795-6. PubMed ID: 26743897
[No Abstract] [Full Text] [Related]
36. Prostate-specific membrane antigen expression in hepatocellular carcinoma: potential use for prognosis and diagnostic imaging.
Tolkach Y; Goltz D; Kremer A; Ahmadzadehfar H; Bergheim D; Essler M; Lam M; de Keizer B; Fischer HP; Kristiansen G
Oncotarget; 2019 Jun; 10(41):4149-4160. PubMed ID: 31289613
[TBL] [Abstract][Full Text] [Related]
37. Dynamic
Golan S; Aviv T; Groshar D; Yakimov M; Zohar Y; Prokocimer Y; Nadu A; Baniel J; Domachevsky L; Bernstine H
J Nucl Med; 2021 Jun; 62(6):773-778. PubMed ID: 33097628
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneous Uptake of 18F-FDG and 68Ga-PSMA-11 in Hepatocellular Carcinoma.
Perez PM; Flavell RR; Kelley RK; Umetsu S; Behr SC
Clin Nucl Med; 2019 Mar; 44(3):e133-e135. PubMed ID: 30624275
[TBL] [Abstract][Full Text] [Related]
39. Expression of glutamate carboxypeptidase II in the glial tumor recurrence evaluated in vivo using radionuclide imaging.
Kunikowska J; Czepczyński R; Pawlak D; Koziara H; Pełka K; Królicki L
Sci Rep; 2022 Jan; 12(1):652. PubMed ID: 35027580
[TBL] [Abstract][Full Text] [Related]
40. Lung uptake detected by
Farolfi A; Telo S; Castellucci P; Morais de Campos AL; Rosado-de-Castro PH; Altino de Almeida S; Artigas C; Scarlattei M; Leal A; Deandreis D; Fanti S; Fendler WP; Mosconi C; Pianori D; Ruffini L; Ceci F
Am J Nucl Med Mol Imaging; 2021; 11(4):300-306. PubMed ID: 34513283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
